RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2

Molecular and Cellular Biology

Volumn 18, Issue 7, 1998, Pages 3647-3658

  Batsché, Eric ^a   Muchardt, Christian ^b   Behrens, Jürgen ^c   Hurst, Helen C ^d   Crémisi, Chantal ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR AP 2; UVOMORULIN; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ARTICLE; BIOGENESIS; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CELL PROLIFERATION; CROSS LINKING; DOWN REGULATION; EPITHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE TARGETING; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FAMILY; SIMIAN VIRUS 40; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALIA; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0031835432     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.7.3647     Document Type: Article

References (58)

1. Adnane, J. P., and D. Robbins. 1995. The retinoblastoma susceptibility gene product regulates Myc-mediated transcription. Oncogene 10:381-387.
2. Batsché, E., M. Lipp, and C. Crémisi. 1994. Transcriptional repression and activation in the same cell type of the human c-myc promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen. Oncogene 9:2235-2243.
3. Bauer, R., A. Imhof, A. Pscherer, H. Kopp, M. Moser, S. Seegers, M. Kerscher, M. Tainsky, F. Hofstaedter, and R. Buettner. 1994. The genomic structure of the human AP-2 transcription factor. Nucleic Acids Res. 22: 1413-1420.
4. Behrens, J., O. Löwrick, L. Klein-Hitpass, and W. Birchmeier. 1991. E-cadherin promoter: functional analysis of a G-C-rich region and an epithelial cell-specific palindromic regulatory element. Proc. Natl. Acad. Sci. USA 88:11495-11499.
5. Behrens, J., M. M. Mareel, F. F. Van Roy, and W. Birchmeier. 1989. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 108:2435-2447.
6. Bernards, R., S. Dessain, and R. Weinberg. 1986. N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell 47:667-674.
7. Birchmeier, W., J. Behrens, M. Weidner, U. Frixen, and J. Schipper. 1991. Dominant and recessive genes involved in tumor cell invasion. Curr. Opin. Cell Biol. 3:832-840.
8. Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151.
9. Bosher, J. M., T. Williams, and H. C. Hurst. 1995. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc. Natl. Acad. Sci. USA 92:744-747.
10. Chen, P.-L., G. J. Riley, S. Chen-Kiang, and W.-H. Lee. 1996. The retinoblastoma protein interacts with and activates NF-IL6. Proc. Natl. Acad. Sci. USA 93:465-469.
11. Chen, P.-L., D. J. Riley, Y. Chen, and W.-H. Lee. 1996. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPα. Genes Dev. 10:2794-2804.
12. Downs, K. M., G. R. Martin, and M. Bishop. 1989. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev. 3:860-869.
13. Gaubatz, S., A. Imhof, R. Dosch, O. Werner, P. Mitchell, R. Buettner, and M. Eilers. 1995. Transcriptional activation by Myc is under negative control by the transcriptional factor AP-2. EMBO J. 14:1508-1519.
14. Gazin, C., S. Dupont de Dinechin, A. Hampe, J. M. Masson, P. Martin, D. Sthelin, and F. Galibert. 1984. Nucleotide sequence of the human c-myc locus: provocative open reading frame within the first exon. EMBO J. 3:383-387.
15. Haas-Kogan, D. A., C. S. Kogan, D. Levi, P. Dazin, A. T'Ang, T. Y. Fung, and M. A. Israel. 1995. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14:461-472.
16. Hann, S. R., M. Dixit, C. R. Sears, and L. Sealy. 1994. The alternatively initiated c-Myc proteins differentially regulate transcription through a non-canonical DNA-binding site. Genes Dev. 8:2441-2452.
17. Hann, S. R., M. W. King, C. W. Bentley, C. W. Anderson, and R. N. Eisenman. 1988. A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell 52:185-195.
18. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual, p. 521-523. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
19. Haupt, Y., S. Rowan, and M. Oren. 1995. p53-mediated apoptosis in Hela cells can be overcome by excess pRB. Oncogene 10:1563-1571.
20. Hennig, G., J. Behrens, M. Truss, S. Frisch, E. Reichmann, and W. Birchmeier. 1995. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11:475-484.
21. Hennig G., O. Löwrick, W. Birchmeier, and J. Behrens. 1996. Mechanisms identified in the transcriptional control of epithelial gene expression. J. Biol. Chem. 271:595-602.
22. Henriksson, M., and B. Lüscher. 1996. Proteins of the myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68:109-182.
23. Hiebert, W. S. 1993. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol. Cell. Biol. 13:3384-3391.
24. Imagawa, M., R. Chiu, and M. Karin. 1987. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51:251-260.
25. Inghirami, G., F. Grignani, L. Sternas, L. Lombardi, D. M. Knowles, and R. Dalla-Favera. 1990. Down-regulation of LFA-1 adhesion receptors by c-myc oncogene in human B lymphoblastoid cells. Science 250:682-686.
26. Kaelin, W. G., W. Krek, W. R. Sellers, I. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingston, and E. K. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351-364.
27. Kannan, P., R. Buettner, P. J. Chiao, S. D. Yim, M. Sarkiss, and M. A. Tainsky. 1994. N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev. 8:1258-1269.
28. Land, H., A. C. Chen, J. P. Morgenstern, L. F. Parada, and R. Weinberg. 1986. Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol. Cell. Biol. 6:1917-1925.
29. Larue, L., M. Ohsugi, J. Hirchenhain, and R. Kemler. 1994. E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc. Natl. Acad. Sci. USA 91:8263-8267.
30. Leask, A., C. Byrne, and E. Fuchs. 1991. Transcription factor AP2 and its role in epidermal-specific gene expression. Proc. Natl. Acad. Sci. USA 88: 7948-7952.
31. Martel, C., E. Batsché, F. Harper, and C. Crémisi. 1996. Inactivation of the retinoblastoma gene product or an RB-related protein by SV40 T antigen in MDCK epithelial cells results in massive apoptosis. Cell Death Differ. 3:61-74.
32. Martel, C., F. Harper, S. Cereghini, N. Veerlé, M. Mareel, and C. Crémisi. 1997. Inactivation of retinoblastoma family proteins by SV40 T antigen results in creation of a hepatocyte growth factor/scatter factor autocrine loop associated with an epithelial-fibroblastoid conversion and invasiveness. Cell Growth Differ. 8:165-178.
33. Martel, C., D. Lallemand, and C. Crémisi. 1995. Specific c-myc and max regulation in epithelial cells. Oncogene 10:2195-2205.
34. Mitchell, P. J., P. M. Timmons, J. M. Hebert, P. W. Rigby, and R. Tjian. 1991. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 5:105-119.
35. Mitchell, P. J., C. Wang, and R. Tjian. 1987. Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen. Cell 50:847-861.
36. Muchardt, C., J.-S. Seeler, A. Nirula, S. Gong, and R. Gaynor. 1992. Transcription factor AP-2 activates gene expression of HTLV-1. EMBO J. 11: 2573-2581.
37. Muchardt, C., J. S. Seeler, and R. B. Gaynor. 1992. Regulation of HTLV-1 gene expression by tax and AP-2. New Biol. 4:541-550.
38. Mugrauer, G., and P. Ekblom. 1991. Contrasting expression patterns of three members of the myc family of protooncogenes in the developing and adult mouse kidney. J. Cell Biol. 112:13-25.
39. Onclercq, R., A. Lavenu, and C. Crémisi. 1989. Pleiotropic derepression of developmentally regulated cellular and viral genes by the product of c-myc protooncogene in undifferentiated embryonal carcinoma cells. Nucleic Acids Res. 17:735-753.
40. Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Munger, P. M. Howley, and H. L. Moses. 1990. TGFβ1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming pRB binding domains. Cell 61:777-785.
41. Prendergast, G. C., L. E. Diamond, D. Dahl, and M. D. Cole. 1990. The c-Myc-regulated gene mr1 encodes plasminogen activator inhibitor 1. Mol. Cell. Biol. 10:1265-1269.
42. Qin, X.-Q., T. Chittenden, D. M. Livingston, and W. G. Kaelin. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953-964.
43. Riethmacher, D., V. Brinkmann, and C. Birchmeier. 1995. A targeted mutation in the mouse E-cadherin gene results in defective preimplantation development. Proc. Natl. Acad. Sci. USA 92:855-859.
44. Ringwald, M., H. Baribault, C. Schmidt, and R. Kemler. 1991. The structure of the gene coding for the mouse cell adhesion molecule uvomorulin. Nucleic Acids Res. 19:6533-6539.
45. Schmid, P., W. Schulz, and H. Hameister. 1989. Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos. Science 243:226-229.
46. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
47. Snow, M. H. L. 1977. Gastrulation in the mouse: growth and regionalization of the epiblast. J. Embryol. Exp. Morphol. 42:293-303.
48. Suen, T.-C., and M.-C. Hung. 1991. c-myc reverses new-induced transformed morphology by transcriptional repression. Mol. Cell. Biol. 11:354-362.
49. Szekely, L., W. Jiang, F. Bulic-Jakus, A. Rosen, N. Ringertz, G. Klein, and K. G. Wiman. 1992. Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ. 3:149-156.
50. Templeton, D. J., S. H. Park, L. Lanier, and R. A. Weinberg. 1991. Non-functional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association and nuclear tethering. Proc Natl. Acad. Sci. USA 88:3033-3037.
51. Thiery, J.-P., J.-L. Duband, U. Rutishauser, and G. M. Edelman. 1982. Cell adhesion molecules in early chicken embryogenesis. Proc. Natl. Acad. Sci. USA 79:6731-6741.
52. Versteeg, R., A. Noordermeer, M. Krüse-Wolters, D. J. Ruiter, and P. I. Schrier. 1988. c-myc down-regulates class 1 HLA expression in human melanomas. EMBO J. 7:1023-1029.
53. Wang, J. Y. J., E. S. Knudsen, and P. J. Welch. 1994. The retinoblastoma tumor-suppressor protein. Adv. Cancer Res. 64:25-85.
54. Weinberg, R. 1991. Tumor suppressor genes. Science 254:1138-1146.
55. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
56. Welch, P. J., and J. Y. Wang. 1995. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev. 9:31-46.
57. Williams, T., A. Admon, B. Lüscher, and R. Tjian. 1988. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev. 2:1557-1569.
58. Yang, B.-S., T. J. Geddes, R. J. Pogulis, B. de Crombrugghe, and S. O. Freytag. 1991. Transcriptional suppression of cellular gene expression by c-Myc. Mol. Cell. Biol. 11:2291-2295.